Buy MRNA

Track MRNA price movements and buy or sell Moderna, Inc.. Analyze and compare investments, track your portfolios, and get the latest news, all powered by an AI investing platform.

$77.48

Today -$0.24 (-0.31%)

Performance:

1W

1M

3M

YTD

1Y

3Y

5Y

10Y

MAX

$77.48
$NaN (--%)last 3 months

Market Open | As of Nov 28, 2023 | 12:22 PM ET ยท Disclosures

About Moderna, Inc.

Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States and internationally. The company has 44 development programs, which includes 26 in clinical trials across seven modalities comprising prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic intracellular therapeutics, and inhaled pulmonary therapeutics. The company has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Key Stats

1W

1M

3M

YTD

1Y

3Y

5Y

10Y

MAX

NO KEY STATS AVAILABLE

From -- to -- | Category:
Disclosures: The performance chart is based on market prices and includes reinvested distributions over the time period selected above the chart, less of expenses, including management fees and other expenses for funds. Performance data represents past performance and does not guarantee future results. Investment return and principal value will fluctuate with market conditions and may be lower or higher when you sell your shares. Current performance may differ from the performance shown. For the most recent month-end performance see provider company's website. For standardized performance and more information on the sponsored funds, see provider company's website.

Before investing, carefully consider a fund's investment objectives, risks, charges and expenses. You can find this and other information in each prospectus, or summary prospectus, if available, at provider company's website. Please read it carefully.